GJB5
From Wikipedia, the free encyclopedia
GJB5 | ||||||
---|---|---|---|---|---|---|
Identifiers | ||||||
Aliases | GJB5, CX31.1, gap junction protein beta 5 | |||||
External IDs | MGI: 95723 HomoloGene: 3858 GeneCards: GJB5 | |||||
Targeted by Drug | ||||||
carbenoxolone, flufenamic acid, caprylic alcohol[1] | ||||||
Orthologs | ||||||
Species | Human | Mouse | ||||
Entrez |
|
|
||||
Ensembl |
|
|
||||
UniProt |
|
|
||||
RefSeq (mRNA) |
|
|
||||
RefSeq (protein) |
|
|
||||
Location (UCSC) | Chr 1: 34.76 – 34.76 Mb | Chr 4: 127.35 – 127.36 Mb | ||||
PubMed search | [2] | [3] | ||||
Wikidata | ||||||
View/Edit Human | View/Edit Mouse |
Gap junction beta-5 protein (GJB5), also known as connexin-31.1 (Cx31.1), is a protein that in humans is encoded by the GJB5 gene.[4]
Function[edit]
Gap junctions are conduits that allow the direct cell-to-cell passage of small cytoplasmic molecules, including ions, metabolic intermediates, and second messengers, and thereby mediate intercellular metabolic and electrical communication. Gap junction channels consist of connexin protein subunits, which are encoded by a multigene family.[4]
References[edit]
Further reading[edit]
- Canova C, Hashibe M, Simonato L, et al. (2009). "Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project.". Cancer Res. 69 (7): 2956–65. doi:10.1158/0008-5472.CAN-08-2604. PMID 19339270.
- Richard G, Smith LE, Bailey RA, et al. (1998). "Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis.". Nat. Genet. 20 (4): 366–9. doi:10.1038/3840. PMID 9843209.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
![]() |
This article on a gene on human chromosome 1 is a stub. You can help Wikipedia by expanding it. |